CAI
HOLD / NEUTRALMeanRevComposite
52.80
Technical
31.20
Fundamental
60.00
Rank
—
Price
17.06
Hurst
-0.02
As of
Jul 14, 2026
Daily
Caris Life Sciences, Inc.
HealthcareBiotechnologyCaris Life Sciences is an artificial intelligence and biotechnology company that offers molecular profiling services combining genetic sequencing with machine learning algorithms. Its product line includes tissue and blood-based sequencing tests for cancer detection, treatment selection, and monitoring of residual disease, along with research services for pharmaceutical companies. The company serves hospitals, medical institutions, and patients primarily in the United States and internationally, operating from its headquarters in Irving, Texas.
Market cap
$8.7B
P/E (trailing)
2.95
P/E (forward)
82.33
PEG ratio
—
Dividend yield
—
Beta
—
52w range
14.19 – 34.12
Return on equity
+20.13%
Profit margin
+10.62%
Revenue growth
+45.40%
Earnings growth
—
Price history
1Y: 28.21 (-15.6%) · range 14.55–33.43
Cycle position
64/ 100 cycle scoreAPPROACHING EXIT
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 8 · NOT READY · exit proximity 38
Conviction
20/ 100 · maturity 100%
VScore.405
Buildup.2034
EMA entry setup.258
Fundamentals.1560
Volume profile
POC
15.83
Price vs POC
+78.2%
Overhead supply
1%
Runway
open sky
Value area 14.49–22.23 · 1% of 120d volume overhead · clean runway
Contributing sources
| Source | Score | Last seen |
|---|---|---|
| earnings-surprise | 0.033 | Sep 3, 2026 |
Forward returns
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | +72.03% | +79.67% | mature |
| 40d | +56.13% | +79.67% | 31/40d |